Search

everythinglearnresearchcommunity

for

Search:↓

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Some alopecia treatments might help treat COVID-19, but more research is needed.

New treatments for hair loss are being developed using molecular biology.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The conference highlighted new diagnostic tools, the role of genetics in hair loss, and emerging treatments.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

The research identified key proteins and genes that may influence wool bending in goats.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Finasteride reduces movement issues in Parkinson's disease rats.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.